These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
3. Tardive dyskinesia and neurotransmitters: effects of sodium valproate, cyproheptadine, oxypertine, hydroxyzine pamoate and Ca-hopantenate on monoamine metabolites, cyclic nucleotides and gamma-aminobutyric acid in human cerebrospinal fluid. Ogawa T; Nagao T; Kashiwabara K; Fujiwara Y; Harada T; Otsuki S Clin Ther; 1984; 7 Spec No():1-17. PubMed ID: 6085032 [TBL] [Abstract][Full Text] [Related]
4. Effect of sodium valproate and baclofen in tardive dyskinesia: clinical and neuroendocrine studies. Nair NP; Lal S; Schwartz G; Thavundayil JX Adv Biochem Psychopharmacol; 1980; 24():437-41. PubMed ID: 6773303 [TBL] [Abstract][Full Text] [Related]
5. Cerebrospinal fluid monoamine metabolites and cyclic nucleotides in chronic schizophrenic patients with tardive dyskinesia or drug-induced tremor. Nagao T; Ohshimo T; Mitsunobu K; Sato M; Otsuki S Biol Psychiatry; 1979 Jun; 14(3):509-23. PubMed ID: 38867 [TBL] [Abstract][Full Text] [Related]
6. Pharmacologic probes of neurotransmitter systems in tardive dyskinesia: implications for clinical management. Nasrallah HA; Dunner FJ; McCalley-Whitters M; Smith RE J Clin Psychiatry; 1986 Feb; 47(2):56-9. PubMed ID: 3003037 [TBL] [Abstract][Full Text] [Related]
7. The effect of sodium valproate on tardive dyskinesia--revisited. Fisk GG; York SM Br J Psychiatry; 1987 Apr; 150():542-6. PubMed ID: 3117156 [TBL] [Abstract][Full Text] [Related]
8. Efficacies of agents related to GABA, dopamine, and acetylcholine in the treatment of tardive dyskinesia [proceedings]. Chien C; Jung K; Ross-Townsend A Psychopharmacol Bull; 1978 Apr; 14(2):20-2. PubMed ID: 26102 [No Abstract] [Full Text] [Related]
9. Yi-gan san for the treatment of neuroleptic-induced tardive dyskinesia: an open-label study. Miyaoka T; Furuya M; Yasuda H; Hayashida M; Nishida A; Inagaki T; Horiguchi J Prog Neuropsychopharmacol Biol Psychiatry; 2008 Apr; 32(3):761-4. PubMed ID: 18201810 [TBL] [Abstract][Full Text] [Related]
11. Clinical effectiveness of the Kampo medicine kamishoyosan for adjunctive treatment of tardive dyskinesia in patients with schizophrenia: a 16-week open trial. Lee JG; Shin BS; Lee YC; Park SW; Kim YH Psychiatry Clin Neurosci; 2007 Oct; 61(5):509-14. PubMed ID: 17875029 [TBL] [Abstract][Full Text] [Related]
12. Risperidone for severe tardive dyskinesia: a 12-week randomized, double-blind, placebo-controlled study. Bai YM; Yu SC; Lin CC J Clin Psychiatry; 2003 Nov; 64(11):1342-8. PubMed ID: 14658949 [TBL] [Abstract][Full Text] [Related]